{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:20:17Z","timestamp":1760955617122,"version":"3.41.0"},"reference-count":38,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":7353,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[1995,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0317167100039883_abs1\"><jats:title><jats:italic><jats:bold>Background<\/jats:bold><\/jats:italic><\/jats:title><jats:p>One of the major symptoms of postpoliomyelitis syndrome (PPS) is disabling generalized fatigue. Subjects with PPS also report muscle fatiguability and display electrophysiologic evidence of anticholinesterase-responsive neuromuscular junction transmission defects, suggesting that anticholinesterase therapy may be useful in the management of disabling fatigue.<\/jats:p><\/jats:sec><jats:sec id=\"S0317167100039883_abs2\"><jats:title><jats:italic><jats:bold>Methods<\/jats:bold><\/jats:italic><\/jats:title><jats:p>We initiated an open trial of the oral anticholinesterase pyridostigmine, up to 180 mg per day, in 27 PPS patients with generalized fatigue and muscle fatiguability. Response to pyridostigmine was assessed with the Hare fatigue scale, the modified Barthel index for activities of daily living, and a modified Klingman mobility index.<\/jats:p><\/jats:sec><jats:sec id=\"S0317167100039883_abs3\"><jats:title><jats:italic><jats:bold>Results<\/jats:bold><\/jats:italic><\/jats:title><jats:p>Two patients could not tolerate the medication. After one month of therapy, 16 patients (64%) reported a reduction in fatigue on the Hare fatigue scale; three of 16 showed improvement on the modified Barthel index for activities of daily living, and two of 16 experienced improvement on a modified Klingman mobility index. Pyridostigmine responders were significantly more fatigued than non-responders on the pre-treatment Hare score, but were not significantly different with regard to age, sex, age at acute poliomyelitis, or severity of acute poliomyelitis.<\/jats:p><\/jats:sec><jats:sec id=\"S0317167100039883_abs4\"><jats:title><jats:italic><jats:bold>Conclusions<\/jats:bold><\/jats:italic><\/jats:title><jats:p>Pyridostigmine may be useful in the management of fatigue in selected patients with PPS. Response to pyridostigmine may be predicted by severity of pre-treatment fatigue.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0317167100039883","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T09:16:23Z","timestamp":1455700583000},"page":"223-227","source":"Crossref","is-referenced-by-count":19,"title":["An Open Trial of Pyridostigmine in Post-poliomyelitis Syndrome"],"prefix":"10.1017","volume":"22","author":[{"given":"Daria A.","family":"Trojan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil R.","family":"Cashman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"year":"1988","author":"Fletcher","first-page":"140","key":"S0317167100039883_ref283"},{"doi-asserted-by":"crossref","unstructured":"Trojan DA , Cashman NR. Fibromyalgia is common in a post-poliomyelitis clinic. Arch Neurol 1995 (in press).","key":"S0317167100039883_ref279","DOI":"10.1001\/archneur.1995.00540300094019"},{"key":"S0317167100039883_ref278","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3928\/0147-7447-19911101-16","article-title":"Polioencephalitis, stress, and the etiology of post-polio sequelae","volume":"14","author":"Bruno","year":"1991","journal-title":"Orthopedics"},{"key":"S0317167100039883_ref276","first-page":"115","volume-title":"In:","author":"Fischer","year":"1987"},{"key":"S0317167100039883_ref275","first-page":"135","volume-title":"In:","author":"Kohl","year":"1987"},{"key":"S0317167100039883_ref274","first-page":"293","volume-title":"In:","author":"Gow","year":"1987"},{"key":"S0317167100039883_ref273","first-page":"S112","article-title":"The effects of pyridostigmine (Mestinon) on isokinetic evaluation of fatigue in subjects with post-poliomyelitis syndrome","volume":"72","author":"Kilfoil","year":"1992","journal-title":"Phys Ther"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref272","DOI":"10.1093\/milmed\/157.5.250"},{"key":"S0317167100039883_ref267","first-page":"253","volume-title":"In:","author":"Granger","year":"1982"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref265","DOI":"10.1001\/archneur.1988.00520300065020"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref263","DOI":"10.1016\/0022-510X(93)90104-7"},{"key":"S0317167100039883_ref277","first-page":"23","volume-title":"In:","author":"Halstead","year":"1991"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref262","DOI":"10.1016\/0022-510X(93)90294-9"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref261","DOI":"10.1002\/mus.880110412"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref260","DOI":"10.1056\/NEJM198604103141505"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref258","DOI":"10.1001\/archneurpsyc.1948.02310050034003"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref257","DOI":"10.1212\/WNL.31.2.202"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref254","DOI":"10.1136\/jnnp.37.5.540"},{"key":"S0317167100039883_ref251","first-page":"199","article-title":"Neurological manifestations of the post-polio syndrome","volume":"3","author":"Jubelt","year":"1987","journal-title":"Crit Rev Neurobiol"},{"key":"S0317167100039883_ref250","first-page":"A42","volume":"70","author":"Trojan","year":"1989","journal-title":"Arch Phys Med Rehabil"},{"key":"S0317167100039883_ref249","first-page":"13","volume-title":"In:","author":"Halstead","year":"1987"},{"key":"S0317167100039883_ref247","first-page":"11","volume-title":"In:","author":"Halstead","year":"1985"},{"key":"S0317167100039883_ref280","first-page":"329","volume-title":"In:","author":"Munsat","year":"1987"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref259","DOI":"10.1002\/mus.880040610"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref248","DOI":"10.1056\/NEJM198707023170102"},{"key":"S0317167100039883_ref252","first-page":"1925","volume-title":"In:","author":"Engel","year":"1986"},{"key":"S0317167100039883_ref266","first-page":"64","article-title":"Simplified scale for rating perceived exertion in patients with coronary artery disease","volume":"2","author":"Hare","year":"1985","journal-title":"Ann Sports Med"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref271","DOI":"10.1001\/jama.1991.03470050093029"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref255","DOI":"10.1016\/0022-510X(75)90166-5"},{"key":"S0317167100039883_ref270","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0022-3565(25)31235-8","article-title":"Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure","volume":"205","author":"Hudson","year":"1978","journal-title":"J Pharm Exp Ther"},{"key":"S0317167100039883_ref246","first-page":"121","volume-title":"In:","author":"Codd","year":"1985"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref264","DOI":"10.1002\/mus.880100603"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref256","DOI":"10.1001\/archneur.1979.00500400056008"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref268","DOI":"10.1016\/0022-510X(84)90050-9"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref269","DOI":"10.1212\/WNL.23.12.1273"},{"key":"S0317167100039883_ref281","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00003086-198808000-00018","article-title":"The post-polio syndrome: an overuse phenomenon","volume":"233","author":"Perry","year":"1988","journal-title":"Clin Orth Rel Res"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref282","DOI":"10.1212\/WNL.44.4.642"},{"doi-asserted-by":"publisher","key":"S0317167100039883_ref253","DOI":"10.1212\/WNL.9.10.627"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100039883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T12:02:20Z","timestamp":1748779340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100039883\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["S0317167100039883"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100039883","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"type":"print","value":"0317-1671"},{"type":"electronic","value":"2057-0155"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}